Technical Analysis for GKOS - Glaukos Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gapped Down | Weakness | 0.76% | |
NR7 | Range Contraction | 1.26% | |
Inside Day | Range Contraction | 1.26% | |
Gapped Up | Strength | 0.97% | |
Gapped Down | Weakness | 1.45% | |
Fell Below 200 DMA | Bearish | 0.99% | |
Overbought Stochastic | Strength | 0.99% | |
Gapped Down | Weakness | 0.99% | |
Crossed Above 200 DMA | Bullish | -1.01% | |
Overbought Stochastic | Strength | -1.01% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
60 Minute Opening Range Breakout | 27 minutes ago |
Up 2% | 27 minutes ago |
Rose Above 200 DMA | about 1 hour ago |
Rose Above Previous Day's High | about 2 hours ago |
200 DMA Resistance | about 2 hours ago |
Get a Trading Sidekick!
- Earnings date: 02/20/2023
Glaukos Corporation Description
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmology Ophthalmic Drainage Glaucoma Vision Implant Blindness Incision Eye Surgery Treatment Of Glaucoma Cornea Intraocular Pressure
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 64.49 |
52 Week Low | 33.33 |
Average Volume | 337,054 |
200-Day Moving Average | 48.78 |
50-Day Moving Average | 45.94 |
20-Day Moving Average | 47.00 |
10-Day Moving Average | 48.44 |
Average True Range | 1.52 |
RSI | 58.68 |
ADX | 19.8 |
+DI | 25.72 |
-DI | 17.81 |
Chandelier Exit (Long, 3 ATRs) | 45.67 |
Chandelier Exit (Short, 3 ATRs) | 45.01 |
Upper Bollinger Bands | 50.87 |
Lower Bollinger Band | 43.13 |
Percent B (%b) | 0.67 |
BandWidth | 16.47 |
MACD Line | 0.85 |
MACD Signal Line | 0.74 |
MACD Histogram | 0.1139 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 50.38 | ||||
Resistance 3 (R3) | 50.31 | 49.54 | 50.03 | ||
Resistance 2 (R2) | 49.54 | 49.00 | 49.57 | 49.91 | |
Resistance 1 (R1) | 48.91 | 48.67 | 49.22 | 48.98 | 49.79 |
Pivot Point | 48.14 | 48.14 | 48.30 | 48.17 | 48.14 |
Support 1 (S1) | 47.51 | 47.61 | 47.83 | 47.58 | 46.77 |
Support 2 (S2) | 46.74 | 47.28 | 46.78 | 46.65 | |
Support 3 (S3) | 46.11 | 46.74 | 46.53 | ||
Support 4 (S4) | 46.18 |